Genome-wide association studies (GWAS) had identified GLIS1 as a susceptibility gene for MVP, but none of carriers with GLIS1 variants in this study had MVP (Yu et al., 2019). The gene discussed is GLIS1; the disease is familial mitral valve prolapse.